JOHNSON & JOHNSON - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
JOHNSON & JOHNSON ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,637,491
-20.4%
394,8340.0%0.97%
-5.5%
Q2 2023$3,312,657
-15.5%
394,8340.0%1.03%
-19.3%
Q1 2023$3,920,702
+142574.7%
394,8340.0%1.28%
+59.4%
Q4 2022$2,748
-99.9%
394,8340.0%0.80%
+29.0%
Q3 2022$2,108,000
+33.8%
394,8340.0%0.62%
+54.2%
Q2 2022$1,575,000
-10.3%
394,8340.0%0.40%
+21.1%
Q1 2022$1,755,000
+11.1%
394,8340.0%0.33%
+84.4%
Q4 2021$1,579,000
-54.5%
394,8340.0%0.18%
-40.8%
Q3 2021$3,467,000394,8340.30%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders